Charlene Rigby

ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA.

Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA.

Sequenta, Inc. operates as a biotech company which discovers and develops clinical diagnostics based on immune system status. It develops molecular diagnostic assays based on a sequencing approach to the profiling of T and B cell receptor repertoires. The firm also provides sequencing-based test for minimal residual disease for leukemia and lymphoma. The company was founded by Thomas D. Willis and Malek Faham in 2007 and is headquartered in South San Francisco, CA.

Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA.

Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT.

Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

PAX Scientific, Inc. specializes in design services related to handling liquids and gases in industrial equipment. It offers an internationally patented technology that improves fluid handling equipment. The firm an engineering research and product design company, provides solutions for fluid-related industrial problems. The company was founded by Jayden David Harmon and Francesca Bertone in 1997 and is headquartered in San Rafael, CA.

Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling.

LifeTech Development Partners LP (LifeTech Development) is a venture capital subsidiary of LifeTech Research, Inc. founded in 2008 by Joel Braunstein. The firm is headquartered in Baltimore, Maryland.

Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA.

Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA.

DecisionQ Corp. offers machine learning, computer science, applied statistics and business leadership. Its provides products and services to financial sector, managed care industries, molecular and genetic diagnostics, insurance and reinsurance, retail, consumer packaged goods, logistics and national defense. The company was founded by Todd A. Radano in 1996 and is headquartered in Arlington, VA.

Cellular Research, Inc. operates as a biotechnology research and development company. It offer Precise assays that provides quantitation of mRNA targets in single cells and small samples; precise predefined gene expression panels; and Pixel system, a detection platform for direct mRNA quantitation from single cells and rare samples. The company’s products are used in various applications that include gene expression validation, RNA-seq validation, pathway validation, and rare transcript detection. The company was founded by Stephen P. A. Fodor, Ari Chaney, Stephen R. Quake and Glenn Fu in 2011 and is headquartered in Menlo Park, CA.

Applied Immunology, Inc. provides specialty assay solutions for the development of therapeutics and diagnostics. It offers custom cell-based assays, GLP bio-analytical assays, and immune monitoring. The company was founded in 2011 and is headquartered in Redwood City, CA.

Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

OmniSeq, Inc. operates molecular diagnostic laboratory. It offers two NGS-based assays: Immune Report CardSM and OmniSeq ComprehensiveSM. The company was founded by Carl Morrison in 2015 and is headquartered in Buffalo, NY.

The Bethesda Group Fund invests in companies located in US. The fund target companies operating in the fields of Precision Medicine, Digital Health and Molecular Diagnostics. It provides financing for both early and growth stage capital requirements.

Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company was founded by Molly He and is headquartered in San Diego, CA.

Part of Yuga Labs, Inc., Wenew, Inc. operates as an online platform for the development of apparel brands. The company is based in Los Angeles, CA. The company was founded by Mike Winkelmann, Tim Smith, Michael H. Figge, Guy Oseary. Michael H. Figge has been the CEO since incorporation. Wenew was acquired by Yuga Labs, Inc. on November 14, 2022.